Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oragenics

1.35
-0.0800-5.59%
Post-market: 1.350.00000.00%19:59 EDT
Volume:211.38K
Turnover:293.37K
Market Cap:1.11M
PE:-0.04
High:1.45
Open:1.45
Low:1.35
Close:1.43
Loading ...

Oragenics Hosts Neurotrauma Medicine Webinar Presentation

TIPRANKS
·
21 May

Oragenics, Inc. Announces Approval to Initiate Phase Ii Concussion Drug Trial in Australia

THOMSON REUTERS
·
13 May

BRIEF-Oragenics Announces Health And Disability Ethics Committee Submission

Reuters
·
09 Apr

Oragenics announces HDEC submission for Phase II concussion trial

TIPRANKS
·
09 Apr

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

GlobeNewswire
·
09 Apr

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

GlobeNewswire
·
08 Apr

BRIEF-Oragenics Provides Q1 2025 Shareholder Update On Strategic And Financial Progress

Reuters
·
27 Mar

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

THOMSON REUTERS
·
27 Mar

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

GlobeNewswire
·
27 Mar

Oragenics submits IB for Phase II clinical trial of ONP-002 in mTBI

TIPRANKS
·
06 Mar

Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI)

GlobeNewswire
·
06 Mar

Oragenics CMO to present at Emergencies in Medicine Conference

TIPRANKS
·
25 Feb

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment

GlobeNewswire
·
25 Feb

Press Release: Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health

Dow Jones
·
24 Feb

Oragenics announces partnership with BRAINBox Solutions

TIPRANKS
·
11 Feb

Oragenics, Inc. Announces Partnership With Brainbox Solutions to Revolutionize Concussion Diagnosis and Treatment

THOMSON REUTERS
·
11 Feb

Oragenics Inc - Partnership to Develop First Intranasal Therapy for Mild Traumatic Brain Injury

THOMSON REUTERS
·
11 Feb

Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment

GlobeNewswire
·
11 Feb

US Stocks Mixed; Walt Disney Posts Upbeat Earnings

Benzinga
·
05 Feb

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025

GlobeNewswire
·
05 Feb